Analyst Research

Report Title Price
Provider: GlobalData
$125.00
Provider: Finlabo SIM Spa
$10.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Echo Therapeutics Inc Announces Termination Of CEO And President-Form 8-K


Thursday, 3 Oct 2013 05:01pm EDT 

Echo Therapeutics Inc reported in its Form 8-K that on September 28, 2013, Patrick T. Mooney, M.D.’s employment as Chief Executive Officer (CEO) and President terminated effective as of September 27, 2013. Dr. Mooney remains a member of the Company’s Board of Directors. As previously announced on August 26, 2013, Robert F. Doman currently serves as Executive Chairman and Interim Chief Executive Officer (CEO). 

Company Quote

19.315
0.525 +2.79%
3:59pm EST